JP2004526124A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004526124A5 JP2004526124A5 JP2002506112A JP2002506112A JP2004526124A5 JP 2004526124 A5 JP2004526124 A5 JP 2004526124A5 JP 2002506112 A JP2002506112 A JP 2002506112A JP 2002506112 A JP2002506112 A JP 2002506112A JP 2004526124 A5 JP2004526124 A5 JP 2004526124A5
- Authority
- JP
- Japan
- Prior art keywords
- species
- binding
- aggregate
- particles
- forming
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000894007 species Species 0.000 description 351
- 238000000034 method Methods 0.000 description 291
- 230000027455 binding Effects 0.000 description 207
- 239000002245 particle Substances 0.000 description 182
- 239000000084 colloidal system Substances 0.000 description 68
- 230000004770 neurodegeneration Effects 0.000 description 65
- 208000015122 neurodegenerative disease Diseases 0.000 description 65
- 230000002776 aggregation Effects 0.000 description 54
- 238000004220 aggregation Methods 0.000 description 54
- 239000003814 drug Substances 0.000 description 52
- 229940079593 drug Drugs 0.000 description 52
- 239000000126 substance Substances 0.000 description 48
- 239000013545 self-assembled monolayer Substances 0.000 description 42
- 239000002094 self assembled monolayer Substances 0.000 description 41
- 230000015572 biosynthetic process Effects 0.000 description 38
- 201000010099 disease Diseases 0.000 description 33
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 33
- 235000018102 proteins Nutrition 0.000 description 21
- 102000004169 proteins and genes Human genes 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 21
- 239000000203 mixture Substances 0.000 description 20
- 230000011664 signaling Effects 0.000 description 20
- 230000008859 change Effects 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 239000002184 metal Substances 0.000 description 14
- 229910052751 metal Inorganic materials 0.000 description 14
- 238000003556 assay Methods 0.000 description 13
- 230000003993 interaction Effects 0.000 description 13
- 108090000765 processed proteins & peptides Proteins 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 238000012544 monitoring process Methods 0.000 description 11
- 229940000406 drug candidate Drugs 0.000 description 8
- 239000011324 bead Substances 0.000 description 7
- 239000013522 chelant Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 150000003573 thiols Chemical class 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 150000007942 carboxylates Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 150000007523 nucleic acids Chemical group 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 230000001747 exhibiting effect Effects 0.000 description 4
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical group [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 230000009871 nonspecific binding Effects 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 210000003660 reticulum Anatomy 0.000 description 4
- 150000003384 small molecules Chemical class 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 3
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 3
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 3
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 3
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 3
- 102000009091 Amyloidogenic Proteins Human genes 0.000 description 3
- 108010048112 Amyloidogenic Proteins Proteins 0.000 description 3
- 102400000068 Angiostatin Human genes 0.000 description 3
- 108010079709 Angiostatins Proteins 0.000 description 3
- 108010031318 Vitronectin Proteins 0.000 description 3
- 102100035140 Vitronectin Human genes 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000007801 affinity label Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000012491 analyte Substances 0.000 description 3
- FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 2
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 description 2
- 102000007590 Calpain Human genes 0.000 description 2
- 108010032088 Calpain Proteins 0.000 description 2
- 108010076667 Caspases Proteins 0.000 description 2
- 102000011727 Caspases Human genes 0.000 description 2
- 101001081479 Homo sapiens Islet amyloid polypeptide Proteins 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 102100025818 Major prion protein Human genes 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 102000019355 Synuclein Human genes 0.000 description 2
- 108050006783 Synuclein Proteins 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 150000004662 dithiols Chemical class 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 108010026424 tau Proteins Proteins 0.000 description 2
- 102000013498 tau Proteins Human genes 0.000 description 2
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
- 108010091326 Cryoglobulins Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102400001047 Endostatin Human genes 0.000 description 1
- 108010079505 Endostatins Proteins 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical group [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000000626 neurodegenerative effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 208000008864 scrapie Diseases 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- JADVWWSKYZXRGX-UHFFFAOYSA-M thioflavine T Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C1=[N+](C)C2=CC=C(C)C=C2S1 JADVWWSKYZXRGX-UHFFFAOYSA-M 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60268900A | 2000-06-23 | 2000-06-23 | |
| US63181800A | 2000-08-03 | 2000-08-03 | |
| PCT/US2001/020232 WO2002001230A2 (en) | 2000-06-23 | 2001-06-25 | Rapid and sensitive detection of protein aggregation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013160587A Division JP2014013242A (ja) | 2000-06-23 | 2013-08-01 | タンパク質凝集の迅速且つ高感度の検出 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004526124A JP2004526124A (ja) | 2004-08-26 |
| JP2004526124A5 true JP2004526124A5 (enExample) | 2008-08-14 |
Family
ID=27084216
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002506112A Pending JP2004526124A (ja) | 2000-06-23 | 2001-06-25 | タンパク質凝集の迅速且つ高感度の検出 |
| JP2013160587A Pending JP2014013242A (ja) | 2000-06-23 | 2013-08-01 | タンパク質凝集の迅速且つ高感度の検出 |
| JP2014240068A Withdrawn JP2015096855A (ja) | 2000-06-23 | 2014-11-27 | タンパク質凝集の迅速且つ高感度の検出 |
| JP2017018410A Expired - Lifetime JP6662797B2 (ja) | 2000-06-23 | 2017-02-03 | タンパク質凝集の迅速且つ高感度の検出 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013160587A Pending JP2014013242A (ja) | 2000-06-23 | 2013-08-01 | タンパク質凝集の迅速且つ高感度の検出 |
| JP2014240068A Withdrawn JP2015096855A (ja) | 2000-06-23 | 2014-11-27 | タンパク質凝集の迅速且つ高感度の検出 |
| JP2017018410A Expired - Lifetime JP6662797B2 (ja) | 2000-06-23 | 2017-02-03 | タンパク質凝集の迅速且つ高感度の検出 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1356296B1 (enExample) |
| JP (4) | JP2004526124A (enExample) |
| AU (1) | AU2001270157A1 (enExample) |
| CA (1) | CA2413884A1 (enExample) |
| WO (1) | WO2002001230A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2413884A1 (en) * | 2000-06-23 | 2002-01-03 | Minerva Biotechnologies Corporation | Rapid and sensitive detection of protein aggregation |
| AU2002216614A1 (en) | 2000-10-03 | 2002-04-15 | Minerva Biotechnologies Corporation | Electronic detection of interaction based on the interruption of flow |
| EP1336104B1 (en) * | 2000-11-01 | 2009-03-25 | Minerva Biotechnologies Corporation | Proteomics based drug comparison methods |
| JP4568840B2 (ja) * | 2004-12-28 | 2010-10-27 | 国立大学法人金沢大学 | アルツハイマー病の検査方法 |
| JP5164971B2 (ja) * | 2006-04-21 | 2013-03-21 | ピープルバイオ，アイ エヌ シー | 三次元的相互作用を用いてマルチマー形成ポリペプチドのモノマーからマルチマーを分別検出する方法 |
| JP2008032554A (ja) * | 2006-07-28 | 2008-02-14 | Japan Science & Technology Agency | βアミロイドオリゴマーを用いたバイオチップおよびアミロイドセンサーならびに生体試料中に存在するβアミロイドの検出方法 |
| JP4969236B2 (ja) * | 2006-12-22 | 2012-07-04 | ローム株式会社 | 生体分子または生体関連物質の測定方法 |
| AU2009246397B2 (en) | 2008-05-13 | 2013-01-17 | University Of Kansas | Metal abstraction peptide (MAP) tag and associated methods |
| JP5205293B2 (ja) * | 2009-01-19 | 2013-06-05 | 富士フイルム株式会社 | 抗体固定基板、並びに該抗体固定基板の製造方法及び利用 |
| CA2753586A1 (en) * | 2009-02-24 | 2010-09-02 | Winton G. Gibbons | Detection of complexes of tau and amyloid |
| EP2491391B1 (en) * | 2009-10-23 | 2018-02-28 | GE Healthcare Bio-Sciences AB | Method for determination of macromolecular multimers |
| WO2013081946A1 (en) | 2011-12-02 | 2013-06-06 | Plaxgen, Inc. | Plaque array method and compositions for forming and detecting plaques |
| WO2013181461A2 (en) | 2012-06-01 | 2013-12-05 | University Of Kansas | Metal abstraction peptide with superoxide dismutase activity |
| KR101448353B1 (ko) | 2012-09-24 | 2014-10-10 | 한양대학교 산학협력단 | 단백질분해효소 활성 분석 방법 및 그 응용 |
| KR101451797B1 (ko) * | 2012-11-07 | 2014-10-16 | 가천대학교 산학협력단 | 멀티머-형성 폴리펩타이드의 멀티머 정량분석을 위한 표준 단백질 복합체 |
| JPWO2015159534A1 (ja) * | 2014-04-16 | 2017-04-13 | 富士フイルム株式会社 | 検出液及びそれを用いたバイオセンシング方法 |
| DE102015003404B4 (de) * | 2015-03-18 | 2021-10-07 | Forschungszentrum Jülich GmbH | Verfahren zur Herstellung eines Standards für den Nachweis von Proteinaggregaten einer Proteinfehlfaltungserkrankung sowie Standard und dessen Verwendung |
| EP3362785A4 (en) * | 2015-10-14 | 2019-06-12 | University Health Network (UHN) | ELECTROCHEMICAL TEST FOR A PROTEIN ANALYTE |
| CN111848470A (zh) * | 2016-08-05 | 2020-10-30 | 深圳深见医药科技有限公司 | 一种含金团簇的物质及其制备方法与应用 |
| US12352746B2 (en) | 2018-01-23 | 2025-07-08 | Oxford University Innovation Limited | Peptide-comprising electrode |
| CA3136356A1 (en) | 2019-04-12 | 2020-10-15 | Ecolab Usa Inc. | Antimicrobial multi-purpose cleaner and methods of making and using the same |
| WO2021075879A2 (ko) * | 2019-10-15 | 2021-04-22 | 고려대학교 산학협력단 | 단백질 응집체 검출용 형광 프로브 화합물 및 이를 포함하는 단백질 응집체 검출용 형광 센서 |
| CN115867807B (zh) | 2020-06-24 | 2025-10-31 | 旭化成生命科学股份有限公司 | 含蛋白质的溶液的评价方法 |
| CA3183682A1 (en) | 2020-06-26 | 2021-12-30 | Minerva Biotechnologies Corporation | Anti-nme antibody and method of treating cancer or cancer metastasis |
| WO2022221683A1 (en) * | 2021-04-16 | 2022-10-20 | Regents Of The University Of Minnesota | Methods and materials for detecting misfolded polypeptides |
| CA3248038A1 (en) | 2022-04-12 | 2023-10-19 | Minerva Biotechnologies Corporation | ANTI-MUC1* VARIABLE ANTIBODIES AND RELATED USES |
| JP2024142624A (ja) | 2023-03-30 | 2024-10-11 | セイコーエプソン株式会社 | 生体物質抽出用磁性ビーズ |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0750112B2 (ja) * | 1988-04-26 | 1995-05-31 | 日本電信電話株式会社 | レーザ磁気免疫測定方法を実施するための検体調整方法 |
| IL85137A (en) * | 1987-01-21 | 1992-02-16 | Ares Serono Res & Dev Ltd | Method of assaying for a ligand using surface plasmon resonance effect |
| US5294369A (en) * | 1990-12-05 | 1994-03-15 | Akzo N.V. | Ligand gold bonding |
| US5369036A (en) * | 1992-07-02 | 1994-11-29 | Becton, Dickinson And Company | Enhancement of signal in immunoassays using microparticles which contain different detectable substances |
| JPH09511492A (ja) * | 1994-02-03 | 1997-11-18 | ザ ピコワー インスティテュート フォア メディカル リサーチ | アミロイドーシスの前進性グリコシル化終末産物仲介モジュレーション用組成物及び方法 |
| US5620850A (en) * | 1994-09-26 | 1997-04-15 | President And Fellows Of Harvard College | Molecular recognition at surfaces derivatized with self-assembled monolayers |
| US6306584B1 (en) * | 1997-01-21 | 2001-10-23 | President And Fellows Of Harvard College | Electronic-property probing of biological molecules at surfaces |
| WO1998037421A1 (en) * | 1997-02-19 | 1998-08-27 | Regents Of The University Of Minnesota | Aβ DEPOSITION INHIBITOR SCREEN USING SYNTHETIC AMYLOID |
| DE19715483A1 (de) * | 1997-04-14 | 1998-10-15 | Boehringer Mannheim Gmbh | Methode zur gleichzeitigen Bestimmung von biomolekularen Wechselwirkungen mittels Plasmonenresonanz undFluoreszenzdetektion |
| JPH1132764A (ja) * | 1997-07-14 | 1999-02-09 | Yakult Honsha Co Ltd | ビフィドバクテリウム・ブレーベ用モノクローナル抗体 |
| JP2001515044A (ja) * | 1997-08-14 | 2001-09-18 | ザ・レジェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア | 蛍光アミロイドＡβペプチドとその使用 |
| WO2000024941A1 (en) * | 1998-10-27 | 2000-05-04 | Clinical Micro Sensors, Inc. | Detection of target analytes using particles and electrodes |
| JP5122705B2 (ja) * | 1999-01-25 | 2013-01-16 | ミナーヴァ・バイオテクノロジーズ・コーポレーション | 神経変性疾患における異常型タンパク質凝集の迅速かつ高感度の検出 |
| CA2413884A1 (en) * | 2000-06-23 | 2002-01-03 | Minerva Biotechnologies Corporation | Rapid and sensitive detection of protein aggregation |
-
2001
- 2001-06-25 CA CA002413884A patent/CA2413884A1/en not_active Abandoned
- 2001-06-25 JP JP2002506112A patent/JP2004526124A/ja active Pending
- 2001-06-25 WO PCT/US2001/020232 patent/WO2002001230A2/en not_active Ceased
- 2001-06-25 AU AU2001270157A patent/AU2001270157A1/en not_active Abandoned
- 2001-06-25 EP EP01948711.5A patent/EP1356296B1/en not_active Expired - Lifetime
-
2013
- 2013-08-01 JP JP2013160587A patent/JP2014013242A/ja active Pending
-
2014
- 2014-11-27 JP JP2014240068A patent/JP2015096855A/ja not_active Withdrawn
-
2017
- 2017-02-03 JP JP2017018410A patent/JP6662797B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6662797B2 (ja) | タンパク質凝集の迅速且つ高感度の検出 | |
| JP2002540383A5 (enExample) | ||
| JP5122705B2 (ja) | 神経変性疾患における異常型タンパク質凝集の迅速かつ高感度の検出 | |
| JP4516273B2 (ja) | オリゴヌクレオチド識別子 | |
| Xia et al. | Design of electrochemical biosensors with peptide probes as the receptors of targets and the inducers of gold nanoparticles assembly on electrode surface | |
| CA2423630C (en) | Magnetic in situ dilution | |
| CN102803962B (zh) | 信号放大微球、其在一步和多步分析放大方法中的用途和用于其生产的方法 | |
| US20050112607A1 (en) | Rapid and sensitive detection of protein aggregation | |
| JP2002535656A (ja) | コロイド固定化種と非コロイド構造上の種との相互作用 | |
| JP6488406B2 (ja) | 青色光を用いて生物有機的に被覆される金および銀ナノ粒子を調製するための方法 | |
| JP4335526B2 (ja) | コロイド構造体および非コロイド構造体による結合スピーシーズの検出 | |
| US10107805B2 (en) | Virus-microbead complex and use thereof | |
| KR101028875B1 (ko) | 세포 내에서 세포내 물질의 생리활성 기능을 조절하는 조절물질을 검출하는 방법 | |
| US20060024230A1 (en) | Customized therapeutics and in situ diagnostics | |
| HK40126758A (en) | Colocalization-by-linkage sandwich assays | |
| AU2008200415A1 (en) | Detection of binding species with colloidal and non-colloidal structures |